Santhera Pharmaceuticals

Santhera Pharmaceuticals is a Swiss specialty pharmaceutical company dedicated to developing and commercializing innovative medicines for rare diseases. They focus specifically on treatments for neuromuscular conditions, which have a severe impact on the lives of affected individuals. They are passionate about providing treatment options for patients in areas with high unmet medical needs. The company prides itself on its dynamic and international working environment, where colleagues are encouraged to take initiative and contribute to the growth of the organization.

Santhera has an exclusive license for AGAMREE® (vamorolone), a first-in-class dissociative steroid, which has been approved for the treatment of Duchenne muscular dystrophy (DMD) in the U.S., the EU and the UK. They are also actively researching and developing other potential treatments for rare neuromuscular diseases. Santhera has a commitment to collaborative partnerships and strives to achieve success through teamwork, both internally and with external partners, including clinicians, scientists, and patient organizations.

Santhera Pharmaceuticals offers a hybrid work model, allowing employees to work both in the office and remotely. The company promotes a fast-paced and dynamic working environment with an entrepreneurial spirit, while also encouraging autonomy and accountability. The company's annual performance management process is implemented across all countries of operation, ensuring that employees receive the coaching, resources, and support needed to achieve their goals.

Santhera Pharmaceuticals offers a comprehensive benefits package that reflects their commitment to employee well-being and professional development. They provide a performance-based reward system, encourage autonomy and accountability, and foster a culture of innovation and hard work. The company also supports professional growth through coaching, resources, and development opportunities. While specific details about benefits are not mentioned, the focus on employee engagement, international opportunities, and a collaborative work environment suggests a robust benefits package designed to attract and retain top talent.

Santhera Pharmaceuticals is a Swiss specialty pharmaceutical company committed to developing and commercializing innovative medicines to meet the needs of patients living with rare diseases, particularly neuromuscular conditions. They are passionate about providing treatment options where none previously existed, focusing on diseases that have a severe impact on the lives of affected individuals, especially children and adults.

Santhera Pharmaceuticals fosters a dynamic and international work environment that encourages a hands-on approach with an entrepreneurial spirit. They value employees who are talented, engaged, and committed to growing the organization. The company promotes autonomy and accountability, creating an atmosphere of innovation and hard work with a performance-based reward system. Their culture emphasizes collaboration and open communication, welcoming new ideas and fostering individual growth beyond job descriptions.

Santhera Pharmaceuticals is committed to fostering a diverse, equitable, and inclusive workplace. They do not tolerate any form of discrimination based on gender, race, origin, or any other personal characteristics. They strive to create an environment where everyone feels valued, respected, and empowered to contribute their unique talents. Their focus is on employing individuals who combine professional experience with passion and effective out-of-the-box thinking, and they offer a workplace culture that actively invites employees to engage in influencing company progress, fostering both personal and professional growth.